China Oncology ›› 2018, Vol. 28 ›› Issue (8): 577-583.doi: 10.19401/j.cnki.1007-3639.2018.08.003
Previous Articles Next Articles
ZHANG Quan, QIU Sifang, ZHAO Kui, ZHU Rong, WANG Yupeng, ZHANG Hai, MOU Lanlan
Online:
Published:
Contact:
Share article
Abstract: Background and purpose: Colorectal cancer (CRC) is a disease that seriously affects the quality of life. This study aimed to investigate the subsets and significance of tumor cell microenvironment T cell in CRC and adenoma. Methods: Immunohistochemistry and flow cytometry were used to test T lymphocyte subsets in 51 healthy subjects (control group), 46 patients with colorectal adenomas (adenoma group), 100 CRC patients (cancer group), and 15 postoperative patients with CRC (postoperative group). Results: The positive rates of CD4+ T cells in the control group, adenoma group and cancer group were 90.00%, 43.75% and 32.65%, respectively. The positive rates of CD8+ T lymphocytes were 30.00%, 56.25% and 75.51%, respectively. The positive rates of CD28+ T lymphocytes were 42.86%, 30.00% and 20.00%, respectively. The levels of CD4+, CD4+/CD8+, CD28+, CD8+CD28+ and CD8-CD28+ in the control group, adenoma group and cancer group gradually decreased, while the CD8+ and CD8+CD28- levels gradually increased (P<0.05). The difference in T cell subsets between preoperative and postoperative patients was statistically significant (P<0.05). Conclusion: CD4+, CD4+/CD8+, CD28+, CD8+CD28+ and CD8-CD28+ in the subgroup of colorectal tumor microenvironment showed a declining trend, while CD8+ and CD8+CD28- showed an increasing trend. Moreover, these trends gradually appeared in precancerous adenomas. After CRC patients underwent tumor resection, their T cell subsets recovered. Therefore, to some extent, the changes of T cell subsets in CRC can predict the development of colorectal disease early.
Key words: Tumor microenvironment, Colorectal cancer, Colorectal adenoma, T lymphocyte subsets, Flow cytometry
ZHANG Quan, QIU Sifang, ZHAO Kui, et al. Subsets and clinical significance of CD4+, CD8+ and CD28+ T lymphocytes in the patients with colorectal carcinoma and adenoma[J]. China Oncology, 2018, 28(8): 577-583.
Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://www.china-oncology.com/EN/10.19401/j.cnki.1007-3639.2018.08.003
http://www.china-oncology.com/EN/Y2018/V28/I8/577